TRADING UPDATES: Hercules and Shearwater win new contracts
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 6.425p on 15-10-2026 at 17:45:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 6.50p |
| Sell | 6.35p |
| Last Trade: | Sell 32.00 at 6.35p |
| Day's Volume: | 32 |
| Last Close: | 6.425p |
| Open: | 6.425p |
| ISIN: | GB00BJN59X09 |
| Day's Range | 6.425p - 6.425p |
| 52wk Range: | 6.05p - 14.75p |
| Market Capitalisation: | £2.82m |
| VWAP: | 6.35p |
| Shares in Issue: | 43.81m |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
Feedback (FDBK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 32 | 6.35p | Ordinary |
09:36:54 - 15-Oct-26 |
| Sell* | 7,539 | 6.50p | Ordinary |
15:33:20 - 14-Oct-26 |
| Sell* | 7,600 | 6.50p | Ordinary |
15:33:20 - 14-Oct-26 |
| Sell* | 7,751 | 6.502p | Ordinary |
15:32:52 - 14-Oct-26 |
| Sell* | 30,642 | 6.54p | Ordinary |
15:32:04 - 14-Oct-26 |
| Sell* | 7,749 | 6.504p | Ordinary |
15:30:57 - 14-Oct-26 |
| Sell* | 30,185 | 6.626p | Ordinary |
15:29:53 - 14-Oct-26 |
| Sell* | 30,244 | 6.626p | Ordinary |
15:29:53 - 14-Oct-26 |
| Sell* | 17,142 | 6.626p | Ordinary |
12:15:30 - 14-Oct-26 |
| Sell* | 577 | 6.55p | Ordinary |
12:01:53 - 14-Oct-26 |
Feedback (FDBK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 14th Jul 2026 7:00 am | RNS | Trading Update |
| 22nd Apr 2026 2:10 pm | RNS | Grant of Options and PDMR dealing |
| 20th Apr 2026 7:00 am | RNS | NHS Progress and Business Update |
| 17th Feb 2026 10:43 am | RNS | Correction: Half-year Report |
| 17th Feb 2026 7:00 am | RNS | Half-year Report |
| 2nd Feb 2026 7:00 am | RNS | Notice of Results & Retail Investor Presentation |
| 5th Jan 2026 4:13 pm | RNS | Holding(s) in Company |
| 23rd Dec 2025 3:44 pm | RNS | Holding(s) in Company |
| 23rd Dec 2025 3:44 pm | RNS | Holding(s) in Company |
| 23rd Dec 2025 3:33 pm | RNS | Director/PDMR Shareholding |